Home / MAPT : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does MAPT make money? Does MAPT have pricing power? What's the Earnings Whisper? Will MAPT profit more as the business scales? What is MAPT's management track record? Is MAPT's current price justified?

Maptelligent, Inc.

$0 -$0.00 (-33.33%)

OTC · 14 Sep 2026 20:00 UTC

Previous Close

Day Range

$0$0

Year Range

$0$0

Market Cap

158.53K

AVG Volume

15.05K

Trailing/Forward PE

0.04/-

PEG ratio

-0

Dividend Yield

Next Earnings Date

Primary Exchange

Other OTC

Revenue (USD)

MAPT Revenue (USD) by year
Period	Revenue (USD)
2022	0
2021	0
2020	0
2019	0
2018	13.14K
2017	52.35K

Net Income (USD)

MAPT Net Income (USD) by year
Period	Net Income (USD)
2022	2.18M
2021	90.76M
2020	-106.25M
2019	-577.28K
2018	-7.47M
2017	-7.39M

Operating Income (USD)

MAPT Operating Income (USD) by year
Period	Operating Income (USD)
2022	-652K
2021	-1.2M
2020	-1.92M
2019	-588.86K
2018	-7.04M
2017	-4.86M

EBITDA (USD)

MAPT EBITDA (USD) by year
Period	EBITDA (USD)
2022	2.71M
2021	92.26M
2020	-104.32M
2019	-272.79K
2018	-6.02M
2017	-5.57M

Cash Flows (USD)

MAPT Cash Flows (USD) by year
Period	Cash Flows (USD)
2022	-714.17K
2021	-900.93K
2020	-670.68K
2019	-89.66K
2018	-671.88K

EPS (USD)

MAPT EPS (USD) by year
Period	EPS (USD)
2022	0
2021	-0
2020	-83.04
2019	-1.15
2018	-13.24
2017	-503200

Expenses (USD)

MAPT Expenses (USD) by year
Period	Expenses (USD)
2022	705.6K
2021	1.2M
2020	1.92M
2019	589.1K
2018	4.59M
2017	1.17M

Cash & Debt (USD)

MAPT Cash & Debt (USD) by year
Period	Cash & Debt (USD)
2022	210.51K
2021	966.68K
2020	61.57K
2019	0
2018	3.09K
2017	4.7K

Debt ratios

MAPT Debt ratios by year
Period	Debt ratios
2022	-0.07
2021	-0.01
2020	-0.01

Margins

MAPT Margins by year
Period	Margins
2018	33.4%
2017	-6591.66%

Return on Capital

MAPT Return on Capital by year
Period	Return on Capital
2022	-86.07%
2021	-1686.42%
2020	100.3%
2019	15.34%
2018	217.27%
2017	761.98%

Shares Outstanding

MAPT Shares Outstanding by year
Period	Shares Outstanding
2022	523.56M
2021	3.62B
2020	1.29M
2019	879.07K
2018	452.98K
2017	13

Book Value Per Share (USD)

MAPT Book Value Per Share (USD) by year
Period	Book Value Per Share (USD)
2022	-0
2021	-0
2020	-82.25
2019	-4.28
2018	-7.59
2017	-74557.08

Total Assets (USD)

MAPT Total Assets (USD) by year
Period	Total Assets (USD)
2022	452.77K
2021	1.16M
2020	247.11K
2019	0
2018	3.09K
2017	141.66K

Employee Count

MAPT Employee Count by year
Period	Employee Count
2022	3
2021	3
2020	3
2019	1.35K
2018	1.35K
2017	1.35K

PE Ratio

MAPT PE Ratio by year
Period	PE Ratio
Sep 26	0.34
Sep 26	0.34
Aug 26	0.34
Aug 26	0.34
Aug 26	0.34
Aug 26	0.34
Jul 26	0.34
Jul 26	0.34
Jul 26	0.34
Jul 26	0.34
Jul 26	0.34
Jun 26	0.34
Jun 26	0.34
Jun 26	0.34
Jun 26	0.34
May 26	0.34
May 26	0.34
May 26	0.52
May 26	0.52
May 26	0.52
Apr 26	0.52
Apr 26	0.52
Apr 26	0.52
Apr 26	0.52
Mar 26	0.52
Mar 26	0.52
Mar 26	0.34
Mar 26	0.52
Feb 26	0
Feb 26	0.52
Feb 26	0.52
Feb 26	0.52
Jan 26	0.52
Jan 26	0.52
Jan 26	0.52
Jan 26	0.52
Jan 26	0.52
Dec 25	0.52
Dec 25	0.52
Dec 25	0.52
Dec 25	0.52
Nov 25	0.52
Nov 25	0.52
Nov 25	0.52
Nov 25	0.52
Oct 25	0.52
Oct 25	0.52
Oct 25	0.52
Oct 25	0.52
Oct 25	0.52
Sep 25	0.52
Sep 25	0.52
Sep 25	0.52
Sep 25	0.52
Aug 25	0.52
Aug 25	0.52
Aug 25	0.52
Aug 25	0.52
Aug 25	0.52
Jul 25	0.52
Jul 25	0.52
Jul 25	0.52
Jul 25	0.52
Jun 25	0.52
Jun 25	0.52
Jun 25	0.52
Jun 25	0.52
May 25	0.52
May 25	0.52
May 25	0.52
May 25	0.52
May 25	0
Apr 25	0.52
Apr 25	0.52
Apr 25	0.52
Apr 25	0.17
Mar 25	0.17
Mar 25	0.17
Mar 25	0.17
Mar 25	0.17
Feb 25	0.17
Feb 25	0.17
Feb 25	0.17
Feb 25	0.17
Jan 25	0.17
Jan 25	0.17
Jan 25	0.17
Jan 25	0.17
Jan 25	0.17
Dec 24	0.17
Dec 24	0.17
Dec 24	0.17
Dec 24	0.17
Nov 24	0.69
Nov 24	0.69
Nov 24	0.69
Nov 24	0.69
Nov 24	0.69
Oct 24	0.69
Oct 24	0.69

Free Cash Flow Yield

MAPT Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	-243.02%
Sep 26	-243.02%
Aug 26	-243.02%
Aug 26	-243.02%
Aug 26	-243.02%
Aug 26	-243.02%
Jul 26	-243.02%
Jul 26	-243.02%
Jul 26	-243.02%
Jul 26	-243.02%
Jul 26	-243.02%
Jun 26	-243.02%
Jun 26	-243.02%
Jun 26	-243.02%
Jun 26	-243.02%
May 26	-243.02%
May 26	-243.02%
May 26	-162.02%
May 26	-162.02%
May 26	-162.02%
Apr 26	-162.02%
Apr 26	-162.02%
Apr 26	-162.02%
Apr 26	-162.02%
Mar 26	-162.02%
Mar 26	-162.02%
Mar 26	-243.02%
Mar 26	-162.02%
Feb 26	-48604.53%
Feb 26	-162.02%
Feb 26	-162.02%
Feb 26	-162.02%
Jan 26	-162.02%
Jan 26	-162.02%
Jan 26	-162.02%
Jan 26	-162.02%
Jan 26	-162.02%
Dec 25	-162.02%
Dec 25	-162.02%
Dec 25	-162.02%
Dec 25	-162.02%
Nov 25	-162.02%
Nov 25	-162.02%
Nov 25	-162.02%
Nov 25	-162.02%
Oct 25	-162.02%
Oct 25	-162.02%
Oct 25	-162.02%
Oct 25	-162.02%
Oct 25	-162.02%
Sep 25	-162.02%
Sep 25	-162.02%
Sep 25	-162.02%
Sep 25	-162.02%
Aug 25	-162.02%
Aug 25	-162.02%
Aug 25	-162.02%
Aug 25	-162.02%
Aug 25	-162.02%
Jul 25	-162.02%
Jul 25	-162.02%
Jul 25	-162.02%
Jul 25	-162.02%
Jun 25	-162.02%
Jun 25	-162.02%
Jun 25	-162.02%
Jun 25	-162.02%
May 25	-162.02%
May 25	-162.02%
May 25	-162.02%
May 25	-162.02%
May 25	-48604.53%
Apr 25	-162.02%
Apr 25	-162.02%
Apr 25	-162.02%
Apr 25	-486.05%
Mar 25	-486.05%
Mar 25	-486.05%
Mar 25	-486.05%
Mar 25	-486.05%
Feb 25	-486.05%
Feb 25	-486.05%
Feb 25	-486.05%
Feb 25	-486.05%
Jan 25	-486.05%
Jan 25	-486.05%
Jan 25	-486.05%
Jan 25	-486.05%
Jan 25	-486.05%
Dec 24	-486.05%
Dec 24	-486.05%
Dec 24	-486.05%
Dec 24	-486.05%
Nov 24	-121.51%
Nov 24	-121.51%
Nov 24	-121.51%
Nov 24	-121.51%
Nov 24	-121.51%
Oct 24	-121.51%
Oct 24	-121.51%

EV/EBITDA

MAPT EV/EBITDA by year
Period	EV/EBITDA
Sep 26	0.89
Sep 26	0.89
Aug 26	0.89
Aug 26	0.89
Aug 26	0.89
Aug 26	0.89
Jul 26	0.89
Jul 26	0.89
Jul 26	0.89
Jul 26	0.89
Jul 26	0.89
Jun 26	0.89
Jun 26	0.89
Jun 26	0.89
Jun 26	0.89
May 26	0.89
May 26	0.89
May 26	0.98
May 26	0.98
May 26	0.98
Apr 26	0.98
Apr 26	0.98
Apr 26	0.98
Apr 26	0.98
Mar 26	0.98
Mar 26	0.98
Mar 26	0.89
Mar 26	0.98
Feb 26	0.7
Feb 26	0.98
Feb 26	0.98
Feb 26	0.98
Jan 26	0.98
Jan 26	0.98
Jan 26	0.98
Jan 26	0.98
Jan 26	0.98
Dec 25	0.98
Dec 25	0.98
Dec 25	0.98
Dec 25	0.98
Nov 25	0.98
Nov 25	0.98
Nov 25	0.98
Nov 25	0.98
Oct 25	0.98
Oct 25	0.98
Oct 25	0.98
Oct 25	0.98
Oct 25	0.98
Sep 25	0.98
Sep 25	0.98
Sep 25	0.98
Sep 25	0.98
Aug 25	0.98
Aug 25	0.98
Aug 25	0.98
Aug 25	0.98
Aug 25	0.98
Jul 25	0.98
Jul 25	0.98
Jul 25	0.98
Jul 25	0.98
Jun 25	0.98
Jun 25	0.98
Jun 25	0.98
Jun 25	0.98
May 25	0.98
May 25	0.98
May 25	0.98
May 25	0.98
May 25	0.7
Apr 25	0.98
Apr 25	0.98
Apr 25	0.98
Apr 25	0.79
Mar 25	0.79
Mar 25	0.79
Mar 25	0.79
Mar 25	0.79
Feb 25	0.79
Feb 25	0.79
Feb 25	0.79
Feb 25	0.79
Jan 25	0.79
Jan 25	0.79
Jan 25	0.79
Jan 25	0.79
Jan 25	0.79
Dec 24	0.79
Dec 24	0.79
Dec 24	0.79
Dec 24	0.79
Nov 24	1.08
Nov 24	1.08
Nov 24	1.08
Nov 24	1.08
Nov 24	1.08
Oct 24	1.08
Oct 24	1.08

No video analysis for this stock yet. Request one from our team.

News: MAPT

gurufocus.com · 14 Jul 2026

Ionis Partner Biogen Presents Phase 2 CELIA Data at AAIC Demonstrating Meaningful Clinical Outcomes and Robust Tau Reduction with Diranersen in Early Alzheimer's Disease

[url="]Ionis Pharmaceuticals, Inc.[/url] (Nasdaq: IONS) today announced that its partner, Biogen, shared data from the Phase 2 CELIA study evaluating diranerse

AI Analysis

Maptelligent, Inc.

Video analysis: MAPT

News: MAPT

Ionis Partner Biogen Presents Phase 2 CELIA Data at AAIC Demonstrating Meaningful Clinical Outcomes and Robust Tau Reduction with Diranersen in Early Alzheimer's Disease

Similar companies